123 related articles for article (PubMed ID: 38583834)
1. An oral bioactive chitosan-decorated doxorubicin nanoparticles/bacteria bioconjugates enhance chemotherapy efficacy in an in-situ breast cancer model.
Li J; Wen Q; Dai J; Wang B; Lu Y; Wu Z; Fan Y; Zeng F; Chen Y; Zhang Y; Chen R; Fu S
Int J Biol Macromol; 2024 May; 267(Pt 1):131428. PubMed ID: 38583834
[TBL] [Abstract][Full Text] [Related]
2. Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer.
Xiao S; Shi H; Zhang Y; Fan Y; Wang L; Xiang L; Liu Y; Zhao L; Fu S
J Nanobiotechnology; 2022 Apr; 20(1):178. PubMed ID: 35366890
[TBL] [Abstract][Full Text] [Related]
3. Bacteria-Driven Tumor Microenvironment-Sensitive Nanoparticles Targeting Hypoxic Regions Enhances the Chemotherapy Outcome of Lung Cancer.
Shi H; Chen L; Liu Y; Wen Q; Lin S; Wen Q; Lu Y; Dai J; Li J; Xiao S; Fu S
Int J Nanomedicine; 2023; 18():1299-1315. PubMed ID: 36945255
[TBL] [Abstract][Full Text] [Related]
4. Self-driven bioactive hybrids co-deliver doxorubicin and indocyanine green nanoparticles for chemo/photothermal therapy of breast cancer.
Lu Y; Chen L; Wu Z; Zhou P; Dai J; Li J; Wen Q; Fan Y; Zeng F; Chen Y; Fu S
Biomed Pharmacother; 2023 Dec; 169():115846. PubMed ID: 37944443
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
Kefayat A; Vaezifar S
Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
[TBL] [Abstract][Full Text] [Related]
6. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
7. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
Deng L; Dong H; Dong A; Zhang J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer.
Rezaei S; de Araújo Júnior RF; da Silva ILG; Schomann T; Eich C; Cruz LJ
Biomater Adv; 2023 Aug; 151():213456. PubMed ID: 37196459
[TBL] [Abstract][Full Text] [Related]
9. A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy.
Niu S; Williams GR; Wu J; Wu J; Zhang X; Chen X; Li S; Jiao J; Zhu LM
J Nanobiotechnology; 2019 Sep; 17(1):95. PubMed ID: 31506085
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
11. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
12. Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor Immunity.
Amini MA; Abbasi AZ; Cai P; Lip H; Gordijo CR; Li J; Chen B; Zhang L; Rauth AM; Wu XY
J Natl Cancer Inst; 2019 Apr; 111(4):399-408. PubMed ID: 30239773
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model.
Dai J; Li J; Zhang Y; Wen Q; Lu Y; Fan Y; Zeng F; Qian Z; Zhang Y; Fu S
Biomater Res; 2023 Oct; 27(1):105. PubMed ID: 37872620
[TBL] [Abstract][Full Text] [Related]
15. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
16. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
[TBL] [Abstract][Full Text] [Related]
17. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
Salehi Khesht AM; Karpisheh V; Sahami Gilan P; Melnikova LA; Olegovna Zekiy A; Mohammadi M; Hojjat-Farsangi M; Majidi Zolbanin N; Mahmoodpoor A; Hassannia H; Aghebati-Maleki L; Jafari R; Jadidi-Niaragh F
Int J Biol Macromol; 2021 Sep; 186():849-863. PubMed ID: 34245737
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhetinic acid remodels the tumor microenvironment and synergizes with doxorubicin for breast cancer treatment in a murine model.
Tang M; Yang M; He K; Li R; Chen X; Wang Y; Zhang X; Qiu T
Nanotechnology; 2021 Apr; 32(18):185702. PubMed ID: 33503591
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
